Page last updated: 2024-08-21

malondialdehyde and ANS (Autonomic Nervous System) Diseases

malondialdehyde has been researched along with ANS (Autonomic Nervous System) Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Kulkarni, YA; Suryavanshi, SV1
Egorova, LS; Liutkevich, AA; Nesina, IA; Poteriaeva, EL; Tepliakov, GV1

Trials

1 trial(s) available for malondialdehyde and ANS (Autonomic Nervous System) Diseases

ArticleYear
[Programs for better health of individuals exposed to increased occupational risk].
    Meditsina truda i promyshlennaia ekologiia, 2010, Issue:8

    Topics: Adaptation, Physiological; Adult; Ambulatory Care; Antioxidants; Autonomic Nervous System Diseases; Baths; Erythrocytes; Health Resorts; Humans; Male; Malondialdehyde; Occupational Diseases; Occupational Health Services; Physical Therapy Modalities; Risk; Siberia; Treatment Outcome; Vibration

2010

Other Studies

1 other study(ies) available for malondialdehyde and ANS (Autonomic Nervous System) Diseases

ArticleYear
Attenuation of Cardiac Autonomic Neuropathy by Escin in Diabetic Rats.
    Pharmacology, 2021, Volume: 106, Issue:3-4

    Topics: Animals; Antioxidants; Autonomic Nervous System Diseases; Catalase; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Escin; Glutathione; Heart; Heart Diseases; Heart Rate; Hemodynamics; Male; Malondialdehyde; Matrix Metalloproteinase 9; Neuroprotective Agents; Oxidative Stress; Rats, Sprague-Dawley; Superoxide Dismutase; Vagus Nerve

2021